Mouse Models for Sporadic Cancer
- 1 March 2001
- journal article
- review article
- Published by Elsevier in Experimental Cell Research
- Vol. 264 (1) , 100-110
- https://doi.org/10.1006/excr.2000.5146
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- The Hallmarks of CancerCell, 2000
- Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFα expression in transgenic miceOncogene, 1999
- Reversible Activation of c-Myc in SkinMolecular Cell, 1999
- Partial rescue of Brca15–6 early embryonic lethality by p53 or p21 null mutationNature Genetics, 1997
- DNA copy number changes associated with characteristic LOH in islet cell carcinomas of transgenic miceGenes, Chromosomes and Cancer, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Mouse models of human disease. Part II: recent progress and future directions.Genes & Development, 1997
- Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic modelsEuropean Journal Of Cancer, 1996
- Conditional gene targeting.Journal of Clinical Investigation, 1996
- Tumor spectrum analysis in p53-mutant miceCurrent Biology, 1994